xanthan gum

DEVICE3 trials

Sponsors

SIFI SpA, Walter Reed National Military Medical Center, Contipro Pharma a.s.

Conditions

Dry EyeEosinophilic EsophagitisSkin Conditions

Unknown Phase

Efficacy of Topical 0.2% Xanthan Gum in Patients With Dry Eye

CompletedNCT01959854

SIFI SpADry Eye

Start: 2013-09-30End: 2014-10-31Updated: 2014-10-16

Comparison of Esophageal Clearance Times of Oral Budesonide Preparations

CompletedNCT02125851

Walter Reed National Military Medical CenterEosinophilic Esophagitis

Start: 2014-01-31End: 2014-02-28Updated: 2014-04-29

The Effect of Peroral Sodium Hyaluronate on the Skin

CompletedNCT07065110

Contipro Pharma a.s.Skin Conditions

Start: 2024-06-17End: 2024-12-13Updated: 2025-07-15

Related Papers

Oral sodium hyaluronate improves skin hydration, barrier function and signs of aging: a randomized, double-blind, placebo-controlled trial in 150 healthy adults.

2025-12-20